Figure S3 from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer

<p>Figure S3. 2D cell viability assay in wildtype and ANGEL2-null RKO cells treated with etoposide (200 nM) for 24 hours.</p>

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awdur:	Christopher August Lucchesi (21643673) (author)
Awduron Eraill:	Saisamkalpa Mantrala (21643676) (author), Darren Tran (21643679) (author), Neelu Batra (15092562) (author), Avani Durve (21643682) (author), Conner Suen (21643685) (author), Jin Zhang (14949675) (author), Paramita Ghosh (21643688) (author), Xinbin Chen (14949678) (author)
Cyhoeddwyd:	2025
Pynciau:	Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development Drug Targets Oncoprotein & tumor suppressor drug targets Gastrointestinal Cancers Colorectal cancer Gene Regulation Posttranscriptional and translational control Oncogenes & Tumor Suppressors TP53 p53
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg